| Pharmaceutical Information |
| Drug Name |
Molindone hydrochloride |
| Drug ID |
BADD_D01488 |
| Description |
An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of clozapine. (From AMA Drug Evaluations Annual, 1994, p283) |
| Indications and Usage |
Molindone is used for the management of the manifestations of psychotic disorders. |
| Marketing Status |
approved |
| ATC Code |
N05AE02 |
| DrugBank ID |
DB01618
|
| KEGG ID |
D00796
|
| MeSH ID |
D008972
|
| PubChem ID |
9883259
|
| TTD Drug ID |
D03AJF
|
| NDC Product Code |
42973-126; 42806-338; 42806-337; 14096-126; 42806-336 |
| UNII |
1DWS68PNE6
|
| Synonyms |
Molindone | Moban | Molindone Hydrochloride | Hydrochloride, Molindone | Molindone Monohydrochloride | Monohydrochloride, Molindone |
|
| Chemical Information |
| Molecular Formula |
C16H25ClN2O2 |
| CAS Registry Number |
15622-65-8 |
| SMILES |
CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
